Showing results (171-180 of 364) with videos related to
Sort By:
Pageof 37
Cancer Chemotherapy and Pharmacology|September 15, 2005
Pharmacokinetics, pharmacodynamics and adherence to oral topotecan in myelodysplastic syndromes: a Cancer and Leukemia Group B studyCheri E Klein, Helen Kastrissios, Antonius A Miller, et al.Prostate Cancer and Prostatic Diseases|October 9, 2013
The effect of the frequency and duration of PSA measurement on PSA doubling time calculations in men with biochemically recurrent prostate cancerC J Paller, D Olatoye, S Xie, et al.British Journal of Cancer|July 2, 1999
The effects of hyperoxic and hypercarbic gases on tumour blood flowT J Dunn, R D Braun, W E Rhemus, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2009
Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokineticsFederico Innocenti, Deanna L Kroetz, Erin Schuetz, et al.Urologic Oncology|June 16, 2014
Elevated alkaline phosphatase velocity strongly predicts overall survival and the risk of bone metastases in castrate-resistant prostate cancerAdam R Metwalli, Inger L Rosner, Jennifer Cullen, et al.Cytokine|July 1, 1995
Evaluation of GM-CSF mouthwash for prevention of chemotherapy-induced mucositis: a randomized, double-blind, dose-ranging studyL Cartee, W P Petros, G L Rosner, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 11, 1991
4-Hydroperoxycyclophosphamide purging of breast cancer from the mononuclear cell fraction of bone marrow in patients receiving high-dose chemotherapy and autologous marrow support: a phase I trialE J Shpall, R B Jones, R C Bast, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Phase I and pharmacologic study of continuous infusion topotecan in combination with cisplatin in patients with advanced cancer: a Cancer and LeukemiaGroup B studyR C Lilenbaum, A A Miller, G Batist, et al.Urologic Oncology|December 26, 2015
A prospective cohort study of treatment decision-making for prostate cancer following participation in a multidisciplinary clinicLauren M Hurwitz, Jennifer Cullen, Sally Elsamanoudi, et al.Molecular and Clinical Oncology|October 4, 2014
Predominance of ERG-negative high-grade prostate cancers in African American menJames Farrell, Denise Young, Yongmei Chen, et al.Pageof 37